Catherine M. Bjerum

Also affiliated with Case Western Reserve University

MedicineImmunology and MicrobiologyEnvironmental ScienceVeterinary

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Moxidectin combination therapies for lymphatic filariasis: an open-label, observer-masked, randomised controlled trial”.

Moxidectin combination therapies for lymphatic filariasis: an open-label, observer-masked, randomised controlled trial

The Lancet Infectious Diseases(2025)10.1016/s1473-3099(25)00111-2

N/A

0.345DataRank · unranked

9 citations

Catherine M. Bjerum, Allassane Ouattara, Toki Pascal Gabo, Charles W. Goss, Daphne Lew +6 more

Pharmacokinetics of Moxidectin combined with Albendazole or Albendazole plus Diethylcarbamazine for Bancroftian Filariasis

PLoS neglected tropical diseases(2023)10.1371/journal.pntd.0011567

N/A

0.314DataRank · unranked

6 citations

Catherine M. Bjerum, Veenu Bala, Allassane Ouattara, Benjamin G. Koudou, Toki Pascal Gabo +8 more

Wb5, a novel biomarker for monitoring efficacy and success of mass drug administration programs for Wuchereria bancrofti elimination

PLoS neglected tropical diseases(2025)10.1371/journal.pntd.0013146

N/A

0DataRank · unranked

0 citations

Catherine M. Bjerum, Benjamin G. Koudou, Taniawati Supali, Philip J. Budge, Peter Fischer +3 more